78 related articles for article (PubMed ID: 2965311)
41. Pharmacologic modification of acute vascular graft thrombosis.
Hanson SR; Reidy MA; Hattori A; Harker LA
Scan Electron Microsc; 1982; (Pt 2):773-9. PubMed ID: 6762650
[TBL] [Abstract][Full Text] [Related]
42. Preservation of platelets and their function in prolonged cardiopulmonary bypass using prostacyclin.
Koshal A; Krausz MM; Utsunomiya T; Hechtman HB; Collins JJ; Cohn LH
Circulation; 1981 Aug; 64(2 Pt 2):II44-8. PubMed ID: 7018736
[TBL] [Abstract][Full Text] [Related]
43. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
44. Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977.
Higgs EA; Higgs GA; Moncada S; Vane JR
Br J Pharmacol; 1997 Feb; 120(4 Suppl):439-43; discussion 437-8. PubMed ID: 9142422
[TBL] [Abstract][Full Text] [Related]
45. Studies on antiplatelet effect of OP-41483, a prostaglandin I2 analog, in experimental animals. I. Effect on platelet function and thrombosis.
Fujitani B; Wakitani K
Jpn J Pharmacol; 1990 Jan; 52(1):123-30. PubMed ID: 2106596
[TBL] [Abstract][Full Text] [Related]
46. Evidence for an increased generation of prostacyclin in the microvasculature and an impairment of the platelet alpha-granule release in chronic renal failure.
Kyrle PA; Stockenhuber F; Brenner B; Gössinger H; Korninger C; Pabinger I; Sunder-Plassmann G; Balcke P; Lechner K
Thromb Haemost; 1988 Oct; 60(2):205-8. PubMed ID: 2975407
[TBL] [Abstract][Full Text] [Related]
47. Prevention of acquired transient defect in platelet plug formation by infused prostacyclin.
Malpass TW; Hanson SR; Savage B; Hessel EA; Harker LA
Blood; 1981 Apr; 57(4):736-40. PubMed ID: 7008866
[TBL] [Abstract][Full Text] [Related]
48. Technical and clinical data on high-performance hemofiltration: twelve patients during one year.
Haas T; Dongradi G; Villeboeuf F; de Viel E; Verrier J; Hillion D
Artif Organs; 1985 May; 9(2):164-8. PubMed ID: 4015452
[TBL] [Abstract][Full Text] [Related]
49. Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit.
Matsuo T; Nakao K; Yamada T; Matsuo O
Thromb Res; 1986 Jan; 41(1):33-41. PubMed ID: 2938301
[TBL] [Abstract][Full Text] [Related]
50. Experience with prostacyclin in cardiopulmonary bypass in dog and man.
Longmore DB
Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):399-412. PubMed ID: 6117901
[TBL] [Abstract][Full Text] [Related]
51. Effect of prostacyclin on the circulatory histamine during cardiopulmonary bypass.
Man WK; Brannan JJ; Fessatidis I; Beckett J; Taylor KM
Agents Actions; 1986 Apr; 18(1-2):182-5. PubMed ID: 2425580
[TBL] [Abstract][Full Text] [Related]
52. The prostacyclin stimulating plasma factor activity improves thromboresistance only if vascular PGI2-production is intact.
Sinzinger H; Ulm MR; Neumann I; Kritz H; O'Grady J; Peskar BA
Thromb Res; 1996 Dec; 84(6):475-80. PubMed ID: 8987168
[TBL] [Abstract][Full Text] [Related]
53. Prostaglandin I2 and the nitric oxide donor molsidomine have synergistic effects on thromboresistance in man.
Sinzinger H; Rauscha F; O'Grady J; Fitscha P
Br J Clin Pharmacol; 1992 Mar; 33(3):289-92. PubMed ID: 1576049
[TBL] [Abstract][Full Text] [Related]
54. Toxicity of plasma from hemodialysis patients treated with heparin or prostacyclin.
Wessel-Aas T; Berg KJ; Widerøe TE; Wirum E; Nilsen T
Acta Med Scand; 1984; 216(1):93-9. PubMed ID: 6385637
[TBL] [Abstract][Full Text] [Related]
55. Assessment of standardized ultrafiltrate production rate using prostacyclin in continuous venovenous hemofiltration.
Journois D; Chanu D; Pouard P; Mauriat P; Safran D
Contrib Nephrol; 1991; 93():202-4. PubMed ID: 1666353
[No Abstract] [Full Text] [Related]
56. Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
Woods HF; Weston MJ; Bunting S; Moncada S; Vane J
Artif Organs; 1980 Aug; 4(3):176-9. PubMed ID: 6998437
[TBL] [Abstract][Full Text] [Related]
57. Neutrophil adhesiveness during prostacyclin and heparin hemodialysis.
Spagnuolo PJ; Bass SH; Smith MC; Danviriyasup K; Dunn MJ
Blood; 1982 Oct; 60(4):924-9. PubMed ID: 7052162
[TBL] [Abstract][Full Text] [Related]
58. "Shear induced platelet activation"--a critical reappraisal.
Wurzinger LJ; Opitz R; Wolf M; Schmid-Schönbein H
Biorheology; 1985; 22(5):399-413. PubMed ID: 2937464
[TBL] [Abstract][Full Text] [Related]
59. Prostacyclin as the sole antithrombotic agent for acute renal failure hemodialysis.
Hory B; Saint-Hillier Y; Perol JC
Nephron; 1983; 33(1):71. PubMed ID: 6339968
[No Abstract] [Full Text] [Related]
60. Use of prostacyclin in patients with continuous hemofiltration after open heart surgery.
Klotz KF; Gellersen H; Brzelinski T; Sedemund-Adib B; Gehring H
Contrib Nephrol; 1995; 116():136-9. PubMed ID: 8529366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
